Clindamycin phosphate 1.2% / Adapalene 0.15% / Benzoyl peroxide 3.1% Therapeutic Cheat Sheet
Cabtreo is the first FDA-approved fixed-dose triple-combination topical treatment for acne vulgaris, pairing a lincosamide antibiotic (clindamycin), a synthetic retinoid (adapalene), and a keratolytic oxidizing agent (benzoyl peroxide) into a single once-daily gel. This formulation targets several pillars of acne pathogenesis simultaneously: cutaneous C. acnes proliferation, abnormal keratinizatio …
Cabtreo is the first FDA-approved fixed-dose triple-combination topical treatment for acne vulgaris, pairing a lincosamide antibiotic (clindamycin), a synthetic retinoid (adapalene), and a keratolytic oxidizing agent (benzoyl peroxide) into a single once-daily gel. This formulation targets several pillars of acne pathogenesis simultaneously: cutaneous C. acnes proliferation, abnormal keratinizatio …
Prurigo nodularis (PN) is far more than just a persistent itch—it is a distinct, neuroimmune-driven disease entity that demands its own targeted diagnostic and therapeutic roadmap. During a standout session at this year's Skin of Color Update in New York City, Dr. Raj Chovatiya challenged the long-held notion that PN is merely a variant of atopic dermatitis. For patients with skin of color, wher …
You have spent years in school learning medicine, completed a dermatology residency, and maybe even pursued fellowship training. After all that hard work, it is finally time to sign your first contract. Unfortunately, while residency prepares us to diagnose disease, perform procedures, and care for patients, it often provides little education on physician employment contracts.
As graduation app …
It’s time for dermatology clinicians to rethink their understanding of obesity and their approach in addressing weight with psoriasis patients. That’s according to Dr. Jennifer Soung, associate professor at Harbor-UCLA Medical Center. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Soung, who shares a comprehensive perspective in addressing psoriatic arthritis an …
Artificial intelligence (AI) is rapidly changing dermatology, and combining AI with dermoscopy is promising unprecedented diagnostic precision. However, as these technologies advance, a critical question remains: Are they designed to serve all patients equally?
Current diagnostic tools often underperform in patients with skin of color due to biases in training data and a lack of standardized i …